Condition: Dengue Fever · Sponsor: Takeda
The main aim of this study is to collect more information on the effectiveness of TDV when used in a pilot public vaccination program for children and adolescents participating in a community-based cohort in Southeast Asian countries with high dengue transmission, specifically Thailand, Indonesia, and Malaysia where TDV is already approved for use. The study will include cohort participants (individual follow-up of 3 years) who may or may not later be vaccinated with TDV as part of a pilot public vaccination program in the study countries. The study will investigate if cohort participants who were vaccinated with TDV have less hospital stays due to dengue than cohort participants who were not vaccinated with TDV. The study will also provide further information on the effectiveness of TDV against the least common dengue virus serotypes (DENV-3 and DENV-4).
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Fakultas Kedokteran Lambung Mangkurat | Banjarmasin, South Kalimantan, Indonesia | Recruiting |
| Fakultas Kedokteran Universitas Sriwijaya | Palembang, South Sumatra, Indonesia | Recruiting |
| Fakultas Kedokteran Universitas Indonesia | Jakarta Pusat, Indonesia | Recruiting |
| Universiti Malaya Medical Centre | Kuala Lumpur, Malaysia | Not Yet Recruiting |
| Pattaya Patamakhun Hospital | Chon Buri, Thailand | Active Not Recruiting |
| Nakhon Phanom Hospital | Nakhon Phanom, Thailand | Active Not Recruiting |
| Phra Nakhon Si Ayutthaya Hospital | Phra Nakhon Si Ayutthaya, Thailand | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06843226